| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 17 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 17 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 17 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 17 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Jun 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 19 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 19 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.082 | Mar 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.082 | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 19 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 19 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.082 | Dec 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.082 | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.097 | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.097 | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.113 | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.113 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 19 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 19 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 0.9 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 0.9 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.093 | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.093 | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 19 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 19 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 1.7 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 1.7 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.083 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.083 | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 17 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 17 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 17 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 17 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Health-Based | N/A | 140 | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 18 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 18 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 18 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 18 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 18 | Apr 4, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 18 | Apr 4, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |